@article{c3a568ed42d342a793bdb4f70767068a,
title = "Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo",
author = "Ying Guo and Hui Yang and Shi Chen and Peng Zhang and Rong Li and Nimer, \{Stephen D.\} and Harbour, \{J. William\} and Mingjiang Xu and Yang, \{Feng Chun\}",
note = "Funding Information: Acknowledgements This work was supported by grants from the National Institutes of Health (CA172408 and CA185751 to F-CY and MX; CA125970 to JWH), National Heart, Lung, and Blood Institute (HL112294 to MX), and Leukemia and Lymphoma Society (F-CY, MX, and SDN). JWH was supported by Research to Prevent Blindness, Inc. Senior Scientific Investigator Award, Melanoma Research Alliance—Melanoma Research Foundation Established Investigator Award, Alcon Research Institute, and a generous gift from Dr. Mark J. Daily. The Bascom Palmer Eye Institute received funding from NIH Core Grant P30EY014801, Department of Defense Grant \#W81XWH-13-1-0048, and a Research to Prevent Blindness Unrestricted Grant. We thank the services provided by the Satellite Histological Core of Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine.",
year = "2018",
month = aug,
day = "1",
doi = "10.1038/s41375-018-0126-9",
language = "English (US)",
volume = "32",
pages = "1834--1837",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
number = "8",
}